236 related articles for article (PubMed ID: 18483394)
1. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
Chen RW; Bemis LT; Amato CM; Myint H; Tran H; Birks DK; Eckhardt SG; Robinson WA
Blood; 2008 Aug; 112(3):822-9. PubMed ID: 18483394
[TBL] [Abstract][Full Text] [Related]
2. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Wiestner A; Tehrani M; Chiorazzi M; Wright G; Gibellini F; Nakayama K; Liu H; Rosenwald A; Muller-Hermelink HK; Ott G; Chan WC; Greiner TC; Weisenburger DD; Vose J; Armitage JO; Gascoyne RD; Connors JM; Campo E; Montserrat E; Bosch F; Smeland EB; Kvaloy S; Holte H; Delabie J; Fisher RI; Grogan TM; Miller TP; Wilson WH; Jaffe ES; Staudt LM
Blood; 2007 Jun; 109(11):4599-606. PubMed ID: 17299095
[TBL] [Abstract][Full Text] [Related]
3. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
[TBL] [Abstract][Full Text] [Related]
4. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ
Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245
[TBL] [Abstract][Full Text] [Related]
6. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
Mohanty A; Sandoval N; Das M; Pillai R; Chen L; Chen RW; Amin HM; Wang M; Marcucci G; Weisenburger DD; Rosen ST; Pham LV; Ngo VN
Oncotarget; 2016 Nov; 7(45):73558-73572. PubMed ID: 27713153
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
Masamha CP; Albrecht TR; Wagner EJ
J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.
Rimokh R; Berger F; Bastard C; Klein B; French M; Archimbaud E; Rouault JP; Santa Lucia B; Duret L; Vuillaume M
Blood; 1994 Jun; 83(12):3689-96. PubMed ID: 8204893
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
Tiemann K; Alluin JV; Honegger A; Chomchan P; Gaur S; Yun Y; Forman SJ; Rossi JJ; Chen RW
Leuk Lymphoma; 2011 Nov; 52(11):2148-54. PubMed ID: 21745168
[TBL] [Abstract][Full Text] [Related]
12. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma.
Williams ME; Nichols GE; Swerdlow SH; Stoler MH
Ann Oncol; 1995 Mar; 6(3):297-9. PubMed ID: 7612496
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Sun F; Fu H; Liu Q; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
FEBS Lett; 2008 Apr; 582(10):1564-8. PubMed ID: 18406353
[TBL] [Abstract][Full Text] [Related]
15. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
[TBL] [Abstract][Full Text] [Related]
16. Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.
Liu H; Huang J; Wang J; Jiang S; Bailey AS; Goldman DC; Welcker M; Bedell V; Slovak ML; Clurman B; Thayer M; Fleming WH; Epner E
J Exp Med; 2008 Aug; 205(8):1843-58. PubMed ID: 18625744
[TBL] [Abstract][Full Text] [Related]
17. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
18. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
19. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]